Edgar Lomax CO Bristol Myers Squibb CO Transaction History

Edgar Lomax CO

$1.6 Billion
Q1 2025

A detailed history of Edgar Lomax CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Edgar Lomax CO holds 87,960 shares of BMY stock, worth $4.14 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

87,960

Previous 195,600 55.03%

Holding current value

$4.14 Million

Previous $11.1 Million 51.51%

% of portfolio

0.34%

Previous 0.72%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$53.9 - $63.11 $5.8 Million - $6.79 Million	-107,640 Reduced 55.03%	87,960 $5.36 Million
Q4 2024 Feb 13, 2025	SELL	$51.92 - $59.94 $196,776 - $227,172	-3,790 Reduced 1.9%	195,600 $11.1 Million
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $125,920 - $164,306	-3,175 Reduced 1.57%	199,390 $10.3 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $105,857 - $139,363	-2,630 Reduced 1.28%	202,565 $8.41 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $4.27 Million - $4.84 Million	88,933 Added 76.49%	205,195 $11.1 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $256,216 - $305,737	-5,285 Reduced 4.35%	116,262 $5.97 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $259,057 - $289,666	-4,475 Reduced 3.55%	121,547 $7.05 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $111,046 - $123,299	-1,743 Reduced 1.36%	126,022 $8.06 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $1.69 Million - $1.92 Million	-25,750 Reduced 16.77%	127,765 $8.86 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $57,865 - $68,521	-845 Reduced 0.55%	153,515 $11 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $208 - $122,944	-1,600 Reduced 1.03%	154,360 $11 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $309,361 - $340,714	4,260 Added 2.81%	155,960 $12 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $101,442 - $121,638	1,650 Added 1.1%	151,700 $11.1 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $81,249 - $94,717	-1,515 Reduced 1.0%	150,050 $9.36 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $174,551 - $204,464	-2,950 Reduced 1.91%	151,565 $8.97 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $363,721 - $396,092	-5,875 Reduced 3.66%	154,515 $10.3 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $1.03 Million - $1.16 Million	-17,355 Reduced 9.76%	160,390 $10.1 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $178,994 - $202,833	-3,100 Reduced 1.71%	177,745 $11 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $424,982 - $470,936	7,400 Added 4.27%	180,845 $10.9 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $188,854 - $220,790	3,445 Added 2.03%	173,445 $10.2 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $7.89 Million - $11.5 Million	170,000 New	170,000 $9.48 Million

Others Institutions Holding BMY

# of Institutions

2,810

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $100B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.

Account